May 15 (Reuters) - Gilead Sciences Inc GILD.O:
GILEAD AND KITE ANNOUNCE PRESENTATION OF TRANSFORMATIVE DATA IN 1L METASTATIC TRIPLE-NEGATIVE BREAST CANCER, UPDATED RESULTS IN MULTIPLE MYELOMA AND EARLY DATA FROM NOVEL INVESTIGATIONAL CAR T-CELL THERAPY TARGETING BRAIN CANCER AT 2025 ASCO AND EHA
Source text: ID:nBw8SXQW4a
Further company coverage: GILD.O
((Reuters.Briefs@thomsonreuters.com;))